Collegium Pharmaceutical
COLL
COLL
157 hedge funds and large institutions have $646M invested in Collegium Pharmaceutical in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 68 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $734M → $646M (-$88.4M)
24% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 68
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
Holders
157
Holding in Top 10
1
Calls
$628K
Puts
$197K
Top Buyers
| 1 | +$5.68M | |
| 2 | +$5.66M | |
| 3 | +$4.58M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.25M |
| 5 |
RA
Royce & Associates
New York
|
+$2.99M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$4.5M | |
| 3 | -$2.84M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$2.62M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$2.28M |